Sutab

Active Ingredient(s): Magnesium Sulfate + Potassium Chloride + Sodium Sulfate
FDA Approved: * November 10, 2020
Pharm Company: * BRAINTREE LABS
Category: Laxative

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Recent Sutab Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Magnesium Sulfate + Potassium Chloride + Sodium Sulfate
  • Powder: 1.6gm/bot + 3.13gm/bot + 17.5gm/bot
  • Solution: 1.6gm/bot + 3.13gm/bot + 17.5gm/bot, 17.5g + 3.13g + 1.6g
  • Suspension: 17.5g + 3.13g + 1.6g
  • Tablet: 0.225gm + 0.188gm + 1.479gm
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Sutab: (1 result)

Sorted by National Drug Code
  • 52268-201 Sutab Oral Tablet by Braintree Laboratories, Inc.

Drugs with one or more similar ingredients: (22 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 11 April 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA